biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > The Biodexa Presentation for Roadshows

<< Previous

Bullboard Posts

Next >>

Comment by Aarcoron Dec 14, 2022 4:21pm

158 Views

Post# 35171774

RE:The Biodexa Presentation for Roadshows

Incredible that the dupes on his board can't figure out anything.

Rathjen is a horrendous, incompetent business manager. A complete failure. I've been saying that for 2+ years as JD, the 7 simps, and guys like Kayaker were telling me I was just a whiner. Now it's like they all knew it all along. Sheesh.

Despite how worthless Rathjen is, it's obvious this is no big clandestine conspiracy. xb3 is worthless, so much so that not a single entity was willing to gamble a few million dollars and get it to stage 2. This takeunder is the way disgusting management exits a fraud.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments